Sartorius Stedim Biotech annual total assets
2020
2021
2022
2023
2024
2025
Sartorius Stedim Biotech Total Assets Growth & History (DIM)
Sartorius Stedim Biotech's total assets was €7.98B for fiscal 2025.
View full Sartorius Stedim Biotech company overviewSartorius Stedim Biotech annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €7.98B | −€272.4M | −3.30% |
| 2024 | 2024-12-31 | €8.26B | €526.3M | +6.81% |
| 2023 | 2023-12-31 | €7.73B | €2.66B | +52.61% |
| 2022 | 2022-12-31 | €5.07B | €1.11B | +28.20% |
| 2021 | 2021-12-31 | €3.95B | €1.09B | +38.31% |
| 2020 | 2020-12-31 | €2.86B | — | — |
Sartorius Stedim Biotech quarterly total assets
Q1.25
Q2.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €7.92B | −€394.9M | −4.75% |
| Q1 2026 | 2026-03-31 | €8.19B | −€113.7M | −1.37% |
| Q4 2025 | 2025-12-31 | €7.98B | — | — |
| Q2 2025 | 2025-06-30 | €8.31B | — | — |
| Q1 2025 | 2025-03-31 | €8.30B | — | — |
Sartorius Stedim Biotech total assets trends
Over the last five fiscal years, Sartorius Stedim Biotech's total assets increased from €2.86B to €7.98B, a change of €5.13B. The latest reported quarter, Q2 2026, shows €7.92B.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
reported total assets
TickerStat uses total assets reported in company official filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sartorius Stedim Biotech source filings ↗